Should multivisceral transplantation be considered in patients colonized with multidrug-resistant Pseudomonas

Diana F Florescu1, Wendy Grant, Jean F Botha

  • 1Transplant Infectious Diseases Program, Infectious Diseases Division, University of Nebraska Medical Center, Omaha, Nebraska NE 68198-5400, USA. dflorescu@unmc.edu

Microbial Drug Resistance (Larchmont, N.Y.)
|November 24, 2011
PubMed

Insights

This study details two multivisceral transplantations in a child with multidrug-resistant Pseudomonas aeruginosa. It highlights challenges and management strategies for transplanting patients colonized with these resistant bacteria.

Area of Science:

  • Organ transplantation
  • Infectious diseases
  • Microbiology

Background:

  • Multivisceral transplantation is a complex procedure.
  • Colonization with multidrug-resistant Pseudomonas aeruginosa poses significant risks in transplant candidates.

Observation:

  • Two subsequent liver-small bowel-pancreas-kidney transplantations were performed in a pediatric patient.
  • The patient was colonized with multidrug-resistant Pseudomonas aeruginosa.

Findings:

  • The report discusses the challenges and potential consequences of transplanting patients colonized with multidrug-resistant Pseudomonas spp.
  • Perioperative and postoperative management strategies are detailed.

Implications:

  • This case highlights the need for careful consideration and management protocols for transplanting patients with multidrug-resistant organisms.
  • It informs clinical decision-making and patient care in complex transplant scenarios.